Back to results
US 8,007,813 B2Granted
CD95-Fc fusion proteins
AssigneesApogenix AG, Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorHenning Walczak
Life of this patent
Estimating the term…
Abstract
The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain.
Claims14
A fusion protein comprising
- (i) at least one first domain comprising a ligand binding domain of the CD95 receptor fused to
- (ii) a heterologous second domain comprising at least a portion of a constant immunoglobulin domain, wherein the fusion protein comprises the amino acid sequence of SEQ ID NO:
- 18.
A fusion protein comprising the amino acid sequence of SEQ ID NO:
- 15.
Dependencies are inferred from the claim text.